Patents by Inventor Nagaraju Banda

Nagaraju Banda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE PARENTERAL FORMULATIONS OF DULOXETINE
    Publication number: 20240058272
    Abstract: The present invention relates to a parenteral lyophilized formulation of duloxetine or a pharmaceutically acceptable salt thereof. Further, this invention relates to duloxetine dissolved in a suitable solvent system comprising one or more buffers, stabilizers, and other pharmaceutically acceptable excipients and subsequently lyophilized. The invention also describes combination formulation of Duloxetine with other active ingredients.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 22, 2024
    Applicant: LEIUTIS PHARMACEUTICALS LLP
    Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA, Santhosh Kumar MANKALA, Suresh PACHAIYAPPAN, Anji Reddy KESHIREDDY
  • NANO LIPID CARRIER SYSTEM FOR IMPROVING PERMEATION OF ACTIVE INGREDIENTS
    Publication number: 20230310465
    Abstract: The present invention relates to a formulation comprising a nano lipid carrier system comprising an active ingredient, low phase transition solid lipid, PEGylated lipid, surfactants and cosolvents etc, dispersed in water or aqueous medium. The hydrodynamic diameter of the nanocarrier system in aqueous media is less than about 1000 nm. The present invention formulation can be in the form of a liquid (solution, suspension, dispersion), liquid filled hard gelatin capsule, soft gelatin capsule or a liquid concentrate.
    Type: Application
    Filed: August 18, 2021
    Publication date: October 5, 2023
    Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA, Arjun NARALA, Naga Udaya Sankar PULLAGURA, Srinath AKULA
  • FORMULATIONS OF VASOPRESSIN
    Publication number: 20230190639
    Abstract: Provided are novel parenteral formulations of vasopressin, including of vasopressin, stabilizers, solvent and other pharmaceutically acceptable excipients. Also provided are ready to use and/ ready to dilute formulations for parenteral administration. Further provided is a process for preparing formulations of vasopressin for parenteral administration.
    Type: Application
    Filed: February 15, 2023
    Publication date: June 22, 2023
    Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA
  • STABLE PARENTERAL FORMULATIONS OF DULOXETINE
    Publication number: 20220409544
    Abstract: The present invention relates to a parenteral lyophilized formulation of duloxetine or a pharmaceutically acceptable salt thereof. Further, this invention relates to duloxetine dissolved in a suitable solvent system comprising one or more buffers, stabilizers, and other pharmaceutically acceptable excipients and subsequently lyophilized. The invention also describes combination formulation of Duloxetine with other active ingredients.
    Type: Application
    Filed: November 30, 2020
    Publication date: December 29, 2022
    Applicant: LEIUTIS PHARMACEUTICALS LLP
    Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA, Santhosh Kumar MANKALA, Suresh PACHAIYAPPAN, Anji Reddy KESHIREDDY
  • TRIPLE COMBINATION FORMULATIONS FOR ANTIEMETIC THERAPY
    Publication number: 20220273630
    Abstract: The disclosure relates to chemotherapy treatments and in particular, formulations for antiemetic therapy. Parenteral formulations comprising Palonosetron, NK1 receptor antagonist and a corticosteroid is provided. Also provided is a process of preparing such formulations.
    Type: Application
    Filed: May 16, 2022
    Publication date: September 1, 2022
    Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA
  • Triple combination formulations for antiemetic therapy
    Patent number: 11364229
    Abstract: The disclosure relates to chemotherapy treatments and in particular, formulations for antiemetic therapy. Parenteral formulations comprising Palonosetron, NK1 receptor antagonist and a corticosteroid is provided. Also provided is a process of preparing such formulations.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: June 21, 2022
    Assignee: LEIUTIS PHARMACEUTICALS PVT, LTD
    Inventors: Chandrashekhar Kocherlakota, Nagaraju Banda
  • NOVEL FORMULATIONS OF VASOPRESSIN
    Publication number: 20210093553
    Abstract: Provided are novel parenteral formulations of vasopressin, including of vasopressin, stabilizers, solvent and other pharmaceutically acceptable excipients. Also provided are ready to use and/ready to dilute formulations for parenteral administration. Further provided is a process for preparing formulations of vasopressin for parenteral administration.
    Type: Application
    Filed: December 21, 2018
    Publication date: April 1, 2021
    Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA
  • ORAL LIQUID FORMULATIONS OF ABIRATERONE
    Publication number: 20210008081
    Abstract: Liquid formulations of Abiraterone intended for oral administration are provided. Also provided are suspension and emulsion formulations of Abiraterone and processes of preparing such formulations. Further, embodiments of the invention relates to Nanoemulsion formulations of Abiraterone including Abiraterone, oil phase, aqueous phase, one or more emulsifying agents and optionally other pharmaceutical excipients, wherein the concentration of excipients are optimized for better stability.
    Type: Application
    Filed: March 28, 2019
    Publication date: January 14, 2021
    Inventors: Chandrashekhar KOCHERLAKOTA, Nagaraju BANDA, Santhosh Kumar MANKALA
  • BENDAMUSTINE FORMULATIONS
    Publication number: 20140142153
    Abstract: Aspects of the present appliction relate to pharmaceutical formulations comprising bendamustine or its pharmaceutically acceptable salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, polymorphs, and mixtures therof, suitable for phamaceutical use. Aspects further provide methods of producing stable bendamustine compositions.
    Type: Application
    Filed: January 25, 2012
    Publication date: May 22, 2014
    Applicants: DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES LTD.
    Inventors: Chandrasekhar Kocherlakota, Tarun Singh, Nagaraju Banda, Nirmal Khati, Sachin Sharma, Prasad Vure, Aparna Mulupuru, Navin Vaya, Amit Anil Charkha
  • Epothilone compound formulations
    Patent number: 8618146
    Abstract: The present application relates to compositions for parenteral administration of epothilone compounds, such as ixabepilone.
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: December 31, 2013
    Assignees: Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories, Inc.
    Inventors: Chandrasekhar Kocherlakota, Tarun Singh, Nagaraju Banda, Prasad Vure, Aparna Mulupuru
  • EPOTHILONE COMPOUND FORMULATIONS
    Publication number: 20120277274
    Abstract: The present application relates to compositions for parenteral administration of epothilone compounds, such as ixabepilone.
    Type: Application
    Filed: January 3, 2012
    Publication date: November 1, 2012
    Inventors: Chandrasekhar Kocherlakota, Tarun Singh, Nagaraju Banda, Prasad Vure, Aparna Mulupuru
  • FORMULATIONS COMPRISING PALONOSETRON
    Publication number: 20120238596
    Abstract: Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant.
    Type: Application
    Filed: May 30, 2012
    Publication date: September 20, 2012
    Applicants: DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES LIMITED
    Inventors: Chandrashekhar Kocherlakota, Sreedhar Bandari, Nagaraju Banda, Kranthi Kumar Hinge, Ramachandra Reddy Yeluri
  • PHARMACEUTICAL FORMULATIONS COMPRISING PEMETREXED
    Publication number: 20110201631
    Abstract: Pharmaceutical formulations comprising amorphous pemetrexed or its salts, and processes to prepare the formulations.
    Type: Application
    Filed: March 9, 2011
    Publication date: August 18, 2011
    Applicants: DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
    Inventors: Chandrasekhar Kocherlakota, Raghuveera Hathibelagal Goruva, Krishnam Raju Kovoru, Nagaraju Banda
  • PHARMACEUTICAL COMPOSITIONS COMPRISING BORONIC ACID COMPOUNDS
    Publication number: 20110178470
    Abstract: Pharmaceutical compositions comprising bortezomib for oral or parenteral administration. Specific aspects relate to stable, sugar free pharmaceutical compositions of bortezomib, including its pharmaceutically acceptable salts or solvates, in the form of ready-to-use solutions, lyophilized forms, or physical admixtures, and the preparation thereof. Other aspects include processes for preparing compositions and methods of using compositions for treating various types of cancers in mammals.
    Type: Application
    Filed: March 31, 2011
    Publication date: July 21, 2011
    Applicants: DR. REDDY'S LABORATORIES LTD., DR. REDDY'S LABORATORIES, INC.
    Inventors: Chandrasekhar Kocherlakota, Lavanya Nallamothu, Krishnam Raju Kovoru, Nagaraju Banda, Mittapally Sridhar, Keni Devendra Chandrkanth, Soogareddy Channareddy Shantreddy, Wagh Sanjay Chhagan, Pillai Raviraj Sukumar, Bandari Sreedhar, Hinge Kranthikumar
  • FORMULATIONS OF AZACITIDINE AND ITS DERIVATIVES
    Publication number: 20110042247
    Abstract: The present invention relates to pharmaceutical formulations comprising azacitidine or its pharmaceutically acceptable salts, including processes for preparing the formulations comprising azacitidine, or salts thereof, and methods of using the formulations for treating various cancer disorders in mammals.
    Type: Application
    Filed: June 25, 2010
    Publication date: February 24, 2011
    Inventors: Chandrasekhar Kocherlakota, Nagaraju Banda, Tarun Singh, Prahlad Pragallapati, Sachin Sharma, Raghu Nandan Srinivasan
  • FORMULATIONS COMPRISING PALONOSETRON
    Publication number: 20100048607
    Abstract: Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant.
    Type: Application
    Filed: August 24, 2009
    Publication date: February 25, 2010
    Inventors: Chandrashekhar Kocherlakota, Sreedhar Bandari, Nagaraju Banda, Kranthi Kumar Hinge, Ramachandra Reddy Yeluri